Alpha-tocopherol to reduced colistin nephrotoxicity in hospitalized patient(BAH)pilot study RCT

Not Applicable

• Conditions: Follow up AKI by cr and serum NGAL; Vitamin E; Colistin; AKI

• Registration Number: TCTR20190730001
• Lead Sponsor: VitaminE

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2019-07-30
• Study Completion: 2019-12-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending (Not yet recruiting)
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Age over 18 year
Inpatients BAH receive colistin

Exclusion Criteria

AKI
Bleeding tendency

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Aki from colistin After 7day expose colistin Rate

Secondary Outcome Measures

Name	Time	Method
Stage of aki 7day after start colistin rate